The Kaiser Family Foundation reported in May 2025 that 12% of its nearly 1,500 survey respondents, including 20% of women, had filled at least one prescription for GLP-1 drugs
Sweeney, and M
High (variant is assumed to have disruptive impact in the protein: stop codon gained and loss of function), low (harmless or unlikely to change protein behavior: synonymous codon), moderate (non-disruptive variant that might alter protein effectiveness: missense codon and inframe codon loss) and modifier (non-coding variants or variants affecting non-coding genes: exon variant and downstream gene variant) are parameters used by SnpEff to correlate SNPs and their putative impact on protein functioning
GLP-1-based therapies and resmetirom operate through distinct and potentially complementary mechanisms: while resmetirom exerts direct hepatic effects by activating THR- to enhance mitochondrial function, reduce hepatic lipogenesis, and promote lipid oxidation specifically in hepatocytes, GLP-1 RAs and multi-agonists address the upstream metabolic drivers of MASLD including insulin resistance, obesity, and systemic inflammation
The fitted models were further refined by rounds of manual model building in COOT 54 and real-space refinement, as implemented in the PHENIX software package 55
What signs mean I should call you right away